Unknown

Dataset Information

0

In vitro reconstitution of EryCIII activity for the preparation of unnatural macrolides.


ABSTRACT: EryCIII is a desosaminyltransferase that converts an inactive macrolide precursor to a biologically active antibiotic. It may have potential for the synthesis of unnatural macrolides with useful biological activities. However, it has been difficult to reconstitute the activity of EryCIII in vitro. We report here that purified, inactive EryCIII can be converted to an active catalyst by the addition of another protein encoded in the same gene cluster, EryCII. The EryCII-treated protein retains activity even when EryCII is removed. We also show that AknT, an activator protein from an unrelated gene cluster, is capable of activating EryCIII. Although the mechanism of activation is not yet understood, we have concluded from these experiments that these antibiotic Gtf activator proteins do not function to deliver substrates to EryCIII and do not exert their effects by forming stable complexes with the Gtf during the glycosyltransfer reaction. We report that activated EryCIII is capable of utilizing an alternative sugar donor, so these results lay the groundwork for the production of novel macrolides.

SUBMITTER: Yuan Y 

PROVIDER: S-EPMC2525786 | biostudies-literature | 2005 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

In vitro reconstitution of EryCIII activity for the preparation of unnatural macrolides.

Yuan Yanqiu Y   Chung Hak Suk HS   Leimkuhler Catherine C   Walsh Christopher T CT   Kahne Daniel D   Walker Suzanne S  

Journal of the American Chemical Society 20051001 41


EryCIII is a desosaminyltransferase that converts an inactive macrolide precursor to a biologically active antibiotic. It may have potential for the synthesis of unnatural macrolides with useful biological activities. However, it has been difficult to reconstitute the activity of EryCIII in vitro. We report here that purified, inactive EryCIII can be converted to an active catalyst by the addition of another protein encoded in the same gene cluster, EryCII. The EryCII-treated protein retains act  ...[more]

Similar Datasets

| S-EPMC3049195 | biostudies-literature
| S-EPMC5362317 | biostudies-literature
| S-EPMC5617736 | biostudies-literature
| S-EPMC122762 | biostudies-literature
| S-EPMC3409725 | biostudies-literature
| S-EPMC3370548 | biostudies-literature
| S-EPMC5505074 | biostudies-literature
| S-EPMC6959987 | biostudies-literature
| S-EPMC3158217 | biostudies-literature
| S-EPMC423294 | biostudies-literature